Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01825135 · ClinicalTrials.gov registry record · NA

Electrical Stimulation to Strengthen Muscles in the Lower Legs in Patients Requiring Prolonged Mechanical Ventilation

A NA study of Muscle Weakness, sponsored by RML Specialty Hospital.

Completed
Registry status
NA
Development phase
57
Enrollment target
1
Study location

NCT01825135 is a NA study of Muscle Weakness that has completed, run by RML Specialty Hospital. The registered enrollment target is 57 participants, below the 73-participant average among 25 other Muscle Weakness trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01825135, a NA study of Muscle Weakness, has completed, sponsored by RML Specialty Hospital.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this proposal is to test the effectiveness of NMES in improving functional status and muscle function in patients requirng prolonged mechanical ventilation

Conditions Studied

Interventions

  • DEVICE sham stimulation
  • DEVICE Neuromuscular electrical stimulation

Study Locations (1)

Illinois

  • RML Specialty Hospital - Hinsdale

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2011-03
Est. Completion 2016-08
Phase NA

Sponsor

RML Specialty Hospital

2 total trials

What the Registry Record Tells You About NCT01825135

The ClinicalTrials.gov registry entry for NCT01825135 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 73-participant average among 25 other Muscle Weakness trials with a reported enrollment target (22% lower). The listed sponsor is RML Specialty Hospital, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Muscle Weakness appearing as the primary indexed condition, and to 2 interventions - of which sham stimulation is the first listed.

NCT01825135 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01825135 about?

NCT01825135 is a clinical study titled "Electrical Stimulation to Strengthen Muscles in the Lower Legs in Patients Requiring Prolonged Mechanical Ventilation". The primary aim of this proposal is to test the effectiveness of NMES in improving functional status and muscle function in patients requirng prolonged mechanical ventilation

What is the current status of trial NCT01825135?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2011-03. Estimated completion is 2016-08.

What conditions does trial NCT01825135 study?

This clinical trial studies the following conditions: Muscle Weakness.

What interventions are being tested in trial NCT01825135?

The interventions under investigation include: sham stimulation (DEVICE), Neuromuscular electrical stimulation (DEVICE).

Who is sponsoring clinical trial NCT01825135?

This trial is sponsored by RML Specialty Hospital, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01825135 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Muscle Weakness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.